Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer [PDF]
, 2020 Background Several scan parameters for PET imaging with F-18-PSMA-11 such as dosage, acquisition time and scan duration were evaluated to determine the most appropriate scan protocol, as well as the effect of furosemide administration on lesion ...
Achten, Eric +7 more
core +2 more sources
Negative multiparametric magnetic resonance imaging for prostate cancer: what's next? [PDF]
, 2018 Multiparametric magnetic resonance imaging (mpMRI) of the prostate has excellent sensitivity in detecting clinically significant prostate cancer (csPCa).
Barchetti, Flavio +12 more
core +1 more source
Peri-prostatic fat volume measurement as a predictive tool for castration resistance in advanced prostate cancer [PDF]
, 2018 Background: Obesity and aggressive prostate cancer (PC) may be linked, but how local peri-prostatic fat relates to tumour response following androgen deprivation therapy (ADT) is unknown.
Ahmad, Imran +5 more
core +1 more source
A cross-sectional comparison of quality of life between physically active and underactive older men with prostate cancer [PDF]
, 2016 Men with prostate cancer experience many side effects and symptoms that may be improved by a physically active lifestyle. It was hypothesized that older men with prostate cancer who were physically active would report significantly higher levels of ...
Boisen, Samara +8 more
core +1 more source
SVU - International Journal of Medical SciencesBackground: The most prevalent type of cancer in males is prostate cancer, with bone being the most common location of metastases. Objectives: to examine the connotation among serum prostate-specific antigen levels and the pathological grade and size ...
Gamal A. Alsagheer +2 more
doaj +1 more source
Urologic Clinics of North America, 1997 Prostate specific antigen is the "gold standard" prostate tissue marker. Based on a reviews of the literature, we present the metabolism, method and lassay clinical use for diagnosis, staging and prostate cancer as well as for monitoring response to treatment. The authors also discuss some situations able to increase the level of this marker.
Lori J. Sokoll, Daniel W. Chan
openaire +3 more sources
Primary goals, information-giving and men\u27s understanding: A qualitative study of Australian and UK doctors\u27 varied communication about PSA screening [PDF]
, 2017 Objectives: (1) To characterise variation in general practitioners’ (GPs’) accounts of communicating with men about prostate cancer screening using the prostate-specific antigen (PSA) test, (2) to characterise GPs’ reasons for communicating as they do ...
Carter, Stacy M +4 more
core +3 more sources
Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera. [PDF]
, 2018 Currently prostate-specific antigen is used for prostate cancer (PCa) screening, however it lacks the necessary specificity for differentiating PCa from other diseases of the prostate such as benign prostatic hyperplasia (BPH), presenting a clinical need
Adusumilli, Ravali +6 more
core +2 more sources
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy : a systematic review and economic evaluation [PDF]
, 2013 Peer reviewedPublisher ...
Boachie, C +11 more
core +3 more sources
PROSTATE SPECIFIC ANTIGEN AFTER TRANSURETHRAL RESECTION OF PROSTATE
Urology Research and Practice, 2019 -
Doğan ERDEN +3 more
doaj +2 more sources